Tiragolumab Antibody
Tiragolumab (MTIG-7192A) is a TIGIT-targeting monoclonal antibody used in cancer immunotherapy research. It is frequently studied in combination with atezolizumab (anti-PD-L1) for solid tumors like NSCLC, with both in vitro assays and in vivo models demonstrating its role in blocking inhibitory checkpoints to enhance anti-tumor T-cell activity.
Product Specifications
Product Name Alternative
MTIG-7192A, RO7092284, RO-7092284, RO 7092284, RG6058, RG-6058, RG6058-10, RG6058-11, RG 6058, Tiragolumab
Target
Immunology/Inflammation related, Others
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
3.63 mg/mL
Purity
95.20% (May vary between batches)
Molecular Weight
148.3 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD25 / IL2RA (Activated Lymphocyte Marker) (IL2RA/2394), CF405S conjugate, 0.1mg/mL
Cofilin 1 (CFL1) pTyr88 Rabbit Polyclonal Antibody
Recombinant Mouse Axl Kinase Protein (His & Fc Tag)
